TCTMD News https://www.tctmd.com/ TCTMD News en Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year https://www.tctmd.com/news/pre-avr-cardiac-damage-partner-patients-linked-poorer-qol-1-year <span class="field field--name-title field--type-string field--label-hidden">Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year</span> <a href="/news/pre-avr-cardiac-damage-partner-patients-linked-poorer-qol-1-year" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Pre-AVR%20Cardiac%20Damage%20in%20PARTNER%20Patients%20Linked%20to%20Poorer%20QoL%20at%201%20Year.jpg?itok=1VZM588k" width="220" height="125" alt="Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/23/2022 - 15:15</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The damage argues for earlier intervention, but FDA reps remain cautious about expanding intervention indications.</div> Fri, 23 Sep 2022 19:15:04 +0000 hdellabella@crf.org 40303 at https://www.tctmd.com Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4 https://www.tctmd.com/news/newest-mitraclip-iteration-performs-well-real-world-expand-g4 <span class="field field--name-title field--type-string field--label-hidden">Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4 </span> <a href="/news/newest-mitraclip-iteration-performs-well-real-world-expand-g4" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Newest%20MitraClip%20Iteration%20Performs%20Well%20in%20the%20Real%20World%20EXPAND%20G4.jpg?itok=gmmXxEd1" width="220" height="125" alt="Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4 " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/23/2022 - 14:43</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">“This expands the spectrum of the TEER-suitable patients and the formerly untreatable patients,” a researcher says.</div> Fri, 23 Sep 2022 18:43:44 +0000 hdellabella@crf.org 40302 at https://www.tctmd.com Most Patient-Reported Outcome Measures in CVD Fall Short https://www.tctmd.com/news/most-patient-reported-outcome-measures-cvd-fall-short <span class="field field--name-title field--type-string field--label-hidden">Most Patient-Reported Outcome Measures in CVD Fall Short </span> <a href="/news/most-patient-reported-outcome-measures-cvd-fall-short" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Most%20Patient-Reported%20Outcome%20Measures%20in%20CVD%20Fall%20Short.jpg?itok=dhQxJA3q" width="220" height="125" alt="Most Patient-Reported Outcome Measures in CVD Fall Short " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/23/2022 - 11:31</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The FDA has set standards for patient-reported outcomes in research and care. In CVD, very few tools available meet the bar.</div> Fri, 23 Sep 2022 15:31:59 +0000 hdellabella@crf.org 40301 at https://www.tctmd.com PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI https://www.tctmd.com/news/pcsk9-inhibitors-pci-swiftly-lower-ldl-c-acs-patients-epic-stemi <span class="field field--name-title field--type-string field--label-hidden">PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI</span> <a href="/news/pcsk9-inhibitors-pci-swiftly-lower-ldl-c-acs-patients-epic-stemi" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/EPIC%20STEMI%20image.jpg?itok=ETHgFl_K" width="220" height="118" alt="PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13991" typeof="schema:Person" property="schema:name" datatype="">swood@tctmd.com</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/22/2022 - 16:07</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Starting alirocumab in the hospital dropped lipids to levels not seen in sham-treated patients, paving the way for larger trials.</div> Thu, 22 Sep 2022 20:07:07 +0000 swood@tctmd.com 40300 at https://www.tctmd.com Valve Fracture for ViV TAVI Linked With Higher Mortality https://www.tctmd.com/news/valve-fracture-viv-tavi-linked-higher-mortality <span class="field field--name-title field--type-string field--label-hidden">Valve Fracture for ViV TAVI Linked With Higher Mortality </span> <a href="/news/valve-fracture-viv-tavi-linked-higher-mortality" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/ValveFracture-TCT2.png?itok=CS1CC3Hw" width="220" height="111" alt="Valve Fracture for ViV TAVI Linked With Higher Mortality " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13991" typeof="schema:Person" property="schema:name" datatype="">swood@tctmd.com</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/22/2022 - 11:39</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">If fracture is needed to replace small surgical valves, it’s best to do it after the transcatheter device is in, registry data suggest.</div> Thu, 22 Sep 2022 15:39:31 +0000 swood@tctmd.com 40299 at https://www.tctmd.com Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes https://www.tctmd.com/news/calcified-nodules-signal-worst-outcome-among-oct-defined-acs-causes <span class="field field--name-title field--type-string field--label-hidden">Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes </span> <a href="/news/calcified-nodules-signal-worst-outcome-among-oct-defined-acs-causes" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/TACTICSsessionpicture.jpg?itok=5oc9ns6A" width="220" height="119" alt="Calcified Nodules Signal Worst Outcome Among OCT-Defined ACS Causes " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13991" typeof="schema:Person" property="schema:name" datatype="">swood@tctmd.com</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/22/2022 - 11:28</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The TACTICS results confirm prior studies, Ziad Ali says. “Whether OCT could help us . . . alter those outcomes remains to be seen.”</div> Thu, 22 Sep 2022 15:28:53 +0000 swood@tctmd.com 40298 at https://www.tctmd.com Rox Heart Radio: Cardiology Evolves https://www.tctmd.com/audio/rox-heart-radio-cardiology-evolves <span class="field field--name-title field--type-string field--label-hidden">Rox Heart Radio: Cardiology Evolves</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13826" typeof="schema:Person" property="schema:name" datatype="">sgutch</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 09/21/2022 - 17:07</span> <div class="field field--name-field-date field--type-datetime field--label-above"> <!-- <div class="field__label">Publish Date</div> --> <div class="field__item">4 days 13 hours ago</div> </div> <div class="field field--name-field-teaser field--type-string-long field--label-above"> <!-- <div class="field__label">Teaser</div> --> <div class="field__item">Roxana Mehran catches up with Rasha Al-Lamee, Shrilla Banerjee, Alaide Chieffo, and Dipti Itchhaporia.</div> </div> Wed, 21 Sep 2022 21:07:56 +0000 sgutch 40297 at https://www.tctmd.com CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA https://www.tctmd.com/news/ccta-patients-prior-cabg-cuts-complications-invasive-angio-bypass-ctca <span class="field field--name-title field--type-string field--label-hidden">CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA</span> <a href="/news/ccta-patients-prior-cabg-cuts-complications-invasive-angio-bypass-ctca" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/BYPASS-CTCA-tct.jpg?itok=02E2UPgF" width="220" height="119" alt="CCTA in Patients With Prior CABG Cuts Complications of Invasive Angio: BYPASS-CTCA" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13991" typeof="schema:Person" property="schema:name" datatype="">swood@tctmd.com</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 09/21/2022 - 13:36</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">One researcher calls this practice a “no-brainer” but acknowledges that not everyone will have access to CT.</div> Wed, 21 Sep 2022 17:36:57 +0000 swood@tctmd.com 40296 at https://www.tctmd.com RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion https://www.tctmd.com/news/rivarad-rivaroxaban-possible-solution-radial-artery-occlusion <span class="field field--name-title field--type-string field--label-hidden">RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion</span> <a href="/news/rivarad-rivaroxaban-possible-solution-radial-artery-occlusion" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/rivarad.jpg?itok=FwIZ7fJU" width="220" height="119" alt="RIVARAD: Rivaroxaban a Possible Solution to Radial Artery Occlusion" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/13991" typeof="schema:Person" property="schema:name" datatype="">swood@tctmd.com</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 09/21/2022 - 13:14</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The idea of preserving the radial artery for future needs, including CABG and hemodialysis, is important, Roxana Mehran says.</div> Wed, 21 Sep 2022 17:14:54 +0000 swood@tctmd.com 40295 at https://www.tctmd.com FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years https://www.tctmd.com/news/favor-iii-china-early-gains-qfr-pci-persist-2-years <span class="field field--name-title field--type-string field--label-hidden">FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years</span> <a href="/news/favor-iii-china-early-gains-qfr-pci-persist-2-years" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/FAVOR.jpg?itok=MFMzok7O" width="220" height="130" alt="FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 09/20/2022 - 09:03</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Reductions in MACE were most pronounced in patients whose treatment plan was changed based on QFR assessment.</div> Tue, 20 Sep 2022 13:03:22 +0000 shuque@crf.org 40294 at https://www.tctmd.com SCAAR Registry Delves Into Left Main Revascularization Outcomes https://www.tctmd.com/news/scaar-registry-delves-left-main-revascularization-outcomes <span class="field field--name-title field--type-string field--label-hidden">SCAAR Registry Delves Into Left Main Revascularization Outcomes</span> <a href="/news/scaar-registry-delves-left-main-revascularization-outcomes" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/SCAAR%20Registry%20Delves%20Into%20Left%20Main%20Revascularization%20Outcomes.jpg?itok=9CpoElFu" width="220" height="125" alt="SCAAR Registry Delves Into Left Main Revascularization Outcomes" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 09/19/2022 - 16:29</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The observational data raised red flags for many, including the fact that CABG survival curves appeared to separate so quickly.</div> Mon, 19 Sep 2022 20:29:46 +0000 hdellabella@crf.org 40212 at https://www.tctmd.com Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances https://www.tctmd.com/news/mix-patient-procedural-and-device-factors-all-drove-tavi-advances <span class="field field--name-title field--type-string field--label-hidden">Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances</span> <a href="/news/mix-patient-procedural-and-device-factors-all-drove-tavi-advances" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Mix%20of%20Patient%2C%20Procedural%2C%20and%20Device%20Factors%20All%20Drove%20TAVI%20Advances.jpg?itok=NvFtZIb5" width="220" height="125" alt="Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 09/19/2022 - 14:14</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Data from the TVT Registry tease out what’s behind reductions in complications and mortality over an 8-year evolution.</div> Mon, 19 Sep 2022 18:14:21 +0000 hdellabella@crf.org 40097 at https://www.tctmd.com Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning https://www.tctmd.com/news/surgical-tavi-explants-are-risky-and-rising-sts-data-carry-warning <span class="field field--name-title field--type-string field--label-hidden">Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning</span> <a href="/news/surgical-tavi-explants-are-risky-and-rising-sts-data-carry-warning" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Surgical%20TAVI%20Explants%20Are%20Risky%20and%20Rising%20STS%20Data%20Carry%20a%20Warning.jpg?itok=o_bRli3n" width="220" height="125" alt="Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 09/19/2022 - 13:59</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Worrisome signals seen in a comparison of redo procedures carry a message for interventionalists and surgeons alike.</div> Mon, 19 Sep 2022 17:59:03 +0000 hdellabella@crf.org 40096 at https://www.tctmd.com Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve https://www.tctmd.com/news/newer-flexnav-delivery-system-improves-placement-portico-tavi-valve <span class="field field--name-title field--type-string field--label-hidden">Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve</span> <a href="/news/newer-flexnav-delivery-system-improves-placement-portico-tavi-valve" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Newer%20FlexNav%20Delivery%20System%20Improves%20Placement%20of%20Portico%20TAVI%20Valve.jpg?itok=7hh3WEzy" width="220" height="125" alt="Newer FlexNav Delivery System Improves Placement of Portico TAVI Valve" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 09/19/2022 - 13:13</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">A relatively high pacemaker rate remains a concern, particularly for younger patients, Robert Bonow said.</div> Mon, 19 Sep 2022 17:13:37 +0000 hdellabella@crf.org 40095 at https://www.tctmd.com Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL https://www.tctmd.com/news/ultrasound-femoral-access-neutral-results-vs-common-sense-universal <span class="field field--name-title field--type-string field--label-hidden">Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL </span> <a href="/news/ultrasound-femoral-access-neutral-results-vs-common-sense-universal" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Ultrasound%20for%20Femoral%20Access%20Neutral%20Results%20vs%20Common%20Sense%20UNIVERSAL.jpg?itok=dXi76MKN" width="220" height="125" alt="Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 09/19/2022 - 09:57</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">UNIVERSAL missed its primary endpoint, but one investigator likened its use to wearing a seatbelt that’s already in the car. </div> Mon, 19 Sep 2022 13:57:41 +0000 hdellabella@crf.org 40094 at https://www.tctmd.com SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss https://www.tctmd.com/news/symplicity-htn-3s-late-surprise-sustained-bp-drop-3-years-despite-earlier-miss <span class="field field--name-title field--type-string field--label-hidden">SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss </span> <a href="/news/symplicity-htn-3s-late-surprise-sustained-bp-drop-3-years-despite-earlier-miss" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/SYMPICITY%20HTN-3%E2%80%99s%20Late%20Surprise%20Sustained%20BP%20Drop%20at%203%20Years%20Despite%20Earlier%20Miss.jpg?itok=wSRZ2j8R" width="220" height="125" alt="SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 09/19/2022 - 09:02</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Experts grappled with how to understand the positive findings given that the trial missed its primary endpoint at 6 months. </div> Mon, 19 Sep 2022 13:02:31 +0000 hdellabella@crf.org 40093 at https://www.tctmd.com RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP https://www.tctmd.com/news/radiance-ii-confirms-ultrasound-based-renal-denervation-lowers-bp <span class="field field--name-title field--type-string field--label-hidden">RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP</span> <a href="/news/radiance-ii-confirms-ultrasound-based-renal-denervation-lowers-bp" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/RADIANCE%20II%20Confirms%20Ultrasound-Based%20Renal%20Denervation%20Lowers%20BP_0.jpg?itok=n-FeM11s" width="220" height="121" alt="RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sun, 09/18/2022 - 15:47</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Some issues still need to be worked out, but denervation will be an important addition for treating high BP, Sripal Bangalore says.</div> Sun, 18 Sep 2022 19:47:43 +0000 hdellabella@crf.org 39852 at https://www.tctmd.com Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test https://www.tctmd.com/news/pulmonary-artery-denervation-idiopathic-pah-ups-6-minute-walk-test <span class="field field--name-title field--type-string field--label-hidden">Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test</span> <a href="/news/pulmonary-artery-denervation-idiopathic-pah-ups-6-minute-walk-test" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Pulmonary%20Artery%20Denervation%20in%20Idiopathic%20PAH%20Ups%206-Minute%20Walk%20Test.jpg?itok=MHokhXgd" width="220" height="125" alt="Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sun, 09/18/2022 - 12:38</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The latest trial of this RF device was sham-controlled, offers hope for despairing patients, and paves the way for a global RCT.</div> Sun, 18 Sep 2022 16:38:07 +0000 hdellabella@crf.org 39850 at https://www.tctmd.com Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI https://www.tctmd.com/news/sizing-mismatch-problem-balloon-expandable-valves-small-annuli-tavi <span class="field field--name-title field--type-string field--label-hidden">Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI</span> <a href="/news/sizing-mismatch-problem-balloon-expandable-valves-small-annuli-tavi" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Sizing%20Mismatch%20a%20Problem%20for%20Balloon-Expandable%20Valves%20in%20Small%20Annuli%20TAVI.jpg?itok=ZmHJ1v3W" width="220" height="125" alt="Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sun, 09/18/2022 - 11:03</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Worryingly, mismatch at 1 year also predicted 3-year all-cause death, spurring calls for RCTs in this setting.</div> Sun, 18 Sep 2022 15:03:43 +0000 hdellabella@crf.org 39849 at https://www.tctmd.com Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes https://www.tctmd.com/news/amulet-watchman-25-laao-devices-provide-comparable-3-year-outcomes <span class="field field--name-title field--type-string field--label-hidden">Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes</span> <a href="/news/amulet-watchman-25-laao-devices-provide-comparable-3-year-outcomes" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Amulet%2C%20Watchman%202.5%20LAAO%20Devices%20Provide%20Comparable%203-Year%20Outcomes.jpg?itok=P-XazkxB" width="220" height="125" alt="Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sun, 09/18/2022 - 10:01</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Extended follow-up of the Amulet IDE trial also hinted at more device-related thrombus with this earlier Watchman iteration.</div> Sun, 18 Sep 2022 14:01:36 +0000 hdellabella@crf.org 39848 at https://www.tctmd.com As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant https://www.tctmd.com/news/time-goes-post-tavi-thrombus-becomes-more-oac-resistant <span class="field field--name-title field--type-string field--label-hidden">As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant</span> <a href="/news/time-goes-post-tavi-thrombus-becomes-more-oac-resistant" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/As%20Time%20Goes%20By%2C%20Post-TAVI%20Thrombus%20Becomes%20More%20OAC%20Resistant.jpg?itok=F5AtlJdS" width="220" height="125" alt="As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sun, 09/18/2022 - 09:51</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">HALT on imaging might be most responsive to treatment if detected within the first year of implantation, say researchers. </div> Sun, 18 Sep 2022 13:51:22 +0000 hdellabella@crf.org 39847 at https://www.tctmd.com To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf https://www.tctmd.com/news/cure-what-ails-us-healthcare-creativity-value-fairness-says-fdas-califf <span class="field field--name-title field--type-string field--label-hidden">To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf</span> <a href="/news/cure-what-ails-us-healthcare-creativity-value-fairness-says-fdas-califf" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/To%20Cure%20What%20Ails%20US%20Healthcare%20Creativity%2C%20Value%2C%20Fairness%2C%20Says%20FDA%E2%80%99s%20Califf%202.jpg?itok=BK9mLZ4B" width="220" height="125" alt="To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sun, 09/18/2022 - 09:05</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">“We have a lot of things that really work well that we don&#039;t use enough,” Robert Califf told TCT attendees in a MedTech keynote.</div> Sun, 18 Sep 2022 13:05:44 +0000 hdellabella@crf.org 39846 at https://www.tctmd.com Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD https://www.tctmd.com/news/both-surgical-percutaneous-closure-boost-survival-post-stemi-vsd <span class="field field--name-title field--type-string field--label-hidden">Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD</span> <a href="/news/both-surgical-percutaneous-closure-boost-survival-post-stemi-vsd" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Both%20Surgical%2C%20Percutaneous%20Closure%20Boost%20Survival%20in%20Post-STEMI%20VSD.jpg?itok=2BPeSwrG" width="220" height="125" alt="Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sun, 09/18/2022 - 08:54</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Registry data point to worse in-hospital outcomes with percutaneous fixes, but surgical turndowns likely played a role.</div> Sun, 18 Sep 2022 12:54:21 +0000 hdellabella@crf.org 39845 at https://www.tctmd.com FLASH: More Data to Support Mechanical Thrombectomy in PE https://www.tctmd.com/news/flash-more-data-support-mechanical-thrombectomy-pe <span class="field field--name-title field--type-string field--label-hidden">FLASH: More Data to Support Mechanical Thrombectomy in PE</span> <a href="/news/flash-more-data-support-mechanical-thrombectomy-pe" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/FLASH%20More%20Data%20to%20Support%20Mechanical%20Thrombectomy%20in%20PE.jpg?itok=QJQ85S0a" width="220" height="125" alt="FLASH: More Data to Support Mechanical Thrombectomy in PE" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sun, 09/18/2022 - 15:39</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">RCTs are needed to see where the clot-retriever strategy “fits in” among other emerging treatment options, says Robert Bonow.</div> Sun, 18 Sep 2022 19:39:09 +0000 hdellabella@crf.org 39851 at https://www.tctmd.com TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip https://www.tctmd.com/news/triluminate-pivotal-trial-first-data-support-safety-efficacy-triclip <span class="field field--name-title field--type-string field--label-hidden">TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip</span> <a href="/news/triluminate-pivotal-trial-first-data-support-safety-efficacy-triclip" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/TRILUMINATE_1.jpg?itok=D7CQIEPE" width="220" height="128" alt="TRILUMINATE Pivotal Trial: First Data Support Safety, Efficacy of TriClip" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sat, 09/17/2022 - 16:36</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">In the trial’s roll-in cohort, 30-day major adverse events were few and 67% saw their TR severity dropped by at least two grades.</div> Sat, 17 Sep 2022 20:36:51 +0000 shuque@crf.org 39551 at https://www.tctmd.com Dedicated Catheter for Acute PE Shows Promise in IDE Trial https://www.tctmd.com/news/dedicated-catheter-acute-pe-shows-promise-ide-trial <span class="field field--name-title field--type-string field--label-hidden">Dedicated Catheter for Acute PE Shows Promise in IDE Trial</span> <a href="/news/dedicated-catheter-acute-pe-shows-promise-ide-trial" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/bashir.JPG?itok=f8B6BE5E" width="220" height="113" alt="Dedicated Catheter for Acute PE Shows Promise in IDE Trial" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sat, 09/17/2022 - 16:27</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The device requires RCT testing against other PE therapies and must show an advantage in hard outcomes, Marc Bonaca says.</div> Sat, 17 Sep 2022 20:27:38 +0000 shuque@crf.org 39550 at https://www.tctmd.com TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR https://www.tctmd.com/news/teer-linked-better-1-year-survival-shock-patients-significant-mr <span class="field field--name-title field--type-string field--label-hidden">TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR</span> <a href="/news/teer-linked-better-1-year-survival-shock-patients-significant-mr" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/TEER%20Linked%20to%20Better%201-Year%20Survival%20in%20Shock%20Patients%20With%20Significant%20MR.jpg?itok=ZBBN2Gtw" width="220" height="125" alt="TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sat, 09/17/2022 - 12:03</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">(UPDATED) A randomized trial is still warranted in cardiogenic shock complicated by significant MR, but enrollment will be tough. </div> Sat, 17 Sep 2022 16:03:40 +0000 hdellabella@crf.org 39549 at https://www.tctmd.com Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID https://www.tctmd.com/news/pascal-teer-device-good-mitraclip-head-head-clasp-iid <span class="field field--name-title field--type-string field--label-hidden">Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID </span> <a href="/news/pascal-teer-device-good-mitraclip-head-head-clasp-iid" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Pascal%20TEER%20Device%20as%20Good%20as%20MitraClip%20in%20Head-to-Head%20CLASP%20IID%202.jpg?itok=kCuvLKkC" width="220" height="125" alt="Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sat, 09/17/2022 - 11:27</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">(UPDATED) The device met its primary noninferiority endpoint for safety and efficacy against MitraClip in degenerative MR patients.</div> Sat, 17 Sep 2022 15:27:39 +0000 hdellabella@crf.org 39548 at https://www.tctmd.com PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope https://www.tctmd.com/news/protected-tavr-no-less-stroke-embolic-protection-some-see-hope <span class="field field--name-title field--type-string field--label-hidden">PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope</span> <a href="/news/protected-tavr-no-less-stroke-embolic-protection-some-see-hope" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/PROTECTED%20TAVR%20No%20Less%20Stroke%20With%20Embolic%20Protection%2C%20but%20Some%20See%20Hope.jpg?itok=4vX59XIN" width="220" height="125" alt="PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Sat, 09/17/2022 - 10:38</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">There were fewer disabling strokes with protection and the procedure itself was safe, so it’s not the end of the story.</div> Sat, 17 Sep 2022 14:38:30 +0000 hdellabella@crf.org 39547 at https://www.tctmd.com HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza https://www.tctmd.com/news/hf-devices-have-role-play-even-todays-gdmt-bonanza <span class="field field--name-title field--type-string field--label-hidden">HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza</span> <a href="/news/hf-devices-have-role-play-even-todays-gdmt-bonanza" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/HF%20Devices%20Have%20a%20Role%20to%20Play%2C%20Even%20With%20Today%E2%80%99s%20GDMT%20Bonanza.jpg?itok=DiYz3CK8" width="220" height="125" alt="HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/16/2022 - 18:04</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">“We should look at drug and device therapies for heart failure as being complementary,” William Abraham says.</div> Fri, 16 Sep 2022 22:04:16 +0000 shuque@crf.org 39545 at https://www.tctmd.com TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US https://www.tctmd.com/news/tavi-sees-rapid-growth-severe-across-age-spectrum-us <span class="field field--name-title field--type-string field--label-hidden">TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US</span> <a href="/news/tavi-sees-rapid-growth-severe-across-age-spectrum-us" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/TAVI%20Sees%20Rapid%20Growth%20for%20Severe%20AS%20Across%20Age%20Spectrum%20in%20US.jpg?itok=nCe_LieJ" width="220" height="125" alt="TAVI Sees Rapid Growth for Severe AS Across Age Spectrum in US" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/16/2022 - 17:55</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">By 2021, the odds a patient under 65 would receive TAVI versus SAVR were about 50/50, a large US database shows.</div> Fri, 16 Sep 2022 21:55:57 +0000 shuque@crf.org 39544 at https://www.tctmd.com Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus https://www.tctmd.com/news/primordial-prevention-end-stage-cvd-experts-call-fresh-focus <span class="field field--name-title field--type-string field--label-hidden">Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus </span> <a href="/news/primordial-prevention-end-stage-cvd-experts-call-fresh-focus" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Primordial%20Prevention%20Before%20End-stage%20CVD%20Experts%20Call%20for%20a%20Fresh%20Focus.jpg?itok=5xLCP6J5" width="220" height="125" alt="Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/16/2022 - 17:37</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The ideal intervention for children or young adults remains elusive, but decades of data will be needed, says Reza Mohebi.</div> Fri, 16 Sep 2022 21:37:37 +0000 shuque@crf.org 39543 at https://www.tctmd.com Obesity May Boost Thrombotic Events in Contraceptive Users, Review Suggests https://www.tctmd.com/news/obesity-may-boost-thrombotic-events-contraceptive-users-review-suggests <span class="field field--name-title field--type-string field--label-hidden">Obesity May Boost Thrombotic Events in Contraceptive Users, Review Suggests</span> <a href="/news/obesity-may-boost-thrombotic-events-contraceptive-users-review-suggests" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Obesity%20May%20Boost%20Thrombotic%20Events%20in%20Contraceptive%20Users%2C%20Review%20Suggests.jpg?itok=lZBvzS-w" width="220" height="125" alt="Obesity May Boost Thrombotic Events in Contraceptive Users, Review Suggests" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/16/2022 - 09:45</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The association highlights the importance of discussing CV health early in a woman’s reproductive years, an expert says.</div> Fri, 16 Sep 2022 13:45:46 +0000 hdellabella@crf.org 39479 at https://www.tctmd.com COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK https://www.tctmd.com/news/courage-and-orbita-had-no-impact-elective-pci-rates-uk <span class="field field--name-title field--type-string field--label-hidden">COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK </span> <a href="/news/courage-and-orbita-had-no-impact-elective-pci-rates-uk" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/COURAGE%20and%20ORBITA%20Had%20No%20Impact%20on%20Elective%20PCI%20Rates%20in%20UK.jpg?itok=JoYkqWn0" width="220" height="125" alt="COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/15/2022 - 17:04</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Even though both RCTs showed no advantage to PCI in stable CAD patients, UK interventionalists didn’t alter their practice. </div> Thu, 15 Sep 2022 21:04:57 +0000 hdellabella@crf.org 39478 at https://www.tctmd.com Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM https://www.tctmd.com/news/pacemaker-doesnt-harm-outcomes-alcohol-septal-ablation-obstructive-hcm <span class="field field--name-title field--type-string field--label-hidden">Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM</span> <a href="/news/pacemaker-doesnt-harm-outcomes-alcohol-septal-ablation-obstructive-hcm" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Pacemaker%20Doesn%E2%80%99t%20Harm%20Outcomes%20of%20Alcohol%20Septal%20Ablation%20for%20Obstructive%20HCM.jpeg?itok=Ten07nuz" width="220" height="136" alt="Pacemaker Doesn’t Harm Outcomes of Alcohol Septal Ablation for Obstructive HCM" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/15/2022 - 13:03</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">“Now we know that we don&#039;t have to worry so much about the risk of PPM” after the procedure, Josef Veselka says.</div> Thu, 15 Sep 2022 17:03:19 +0000 shuque@crf.org 39477 at https://www.tctmd.com FDA Approves Pascal TEER Device for Degenerative MR https://www.tctmd.com/news/fda-approves-pascal-teer-device-degenerative-mr <span class="field field--name-title field--type-string field--label-hidden">FDA Approves Pascal TEER Device for Degenerative MR</span> <a href="/news/fda-approves-pascal-teer-device-degenerative-mr" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Approved%20-650x330-01%20_%20new%20image.jpg?itok=uvkUQydV" width="220" height="112" alt="FDA Approves Pascal TEER Device for Degenerative MR" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/15/2022 - 11:22</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/shelley-wood" hreflang="en">Shelley Wood</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The CLASP IID randomized trial comparing the Pascal to the MitraClip will be presented Saturday at the TCT 2022 meeting.</div> Thu, 15 Sep 2022 15:22:39 +0000 shuque@crf.org 39476 at https://www.tctmd.com AI Tool Can Quantify CAC—and Associated CV Risk—From PET https://www.tctmd.com/news/ai-tool-can-quantify-cac-and-associated-cv-risk-pet <span class="field field--name-title field--type-string field--label-hidden">AI Tool Can Quantify CAC—and Associated CV Risk—From PET </span> <a href="/news/ai-tool-can-quantify-cac-and-associated-cv-risk-pet" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/AI%20Tool%20Can%20Quantify%20CAC%E2%80%94and%20Associated%20CV%20Risk%E2%80%94From%20PET.jpg?itok=UK79M6fj" width="220" height="125" alt="AI Tool Can Quantify CAC—and Associated CV Risk—From PET " loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 09/14/2022 - 12:55</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Once in clinical use, the model can save patients from additional radiation exposure and reduce costs, Piotr Slomka says.</div> Wed, 14 Sep 2022 16:55:34 +0000 hdellabella@crf.org 39474 at https://www.tctmd.com Checking Cumulative High BP Exposure Hones CV Risk Prediction in Diabetes https://www.tctmd.com/news/checking-cumulative-high-bp-exposure-hones-cv-risk-prediction-diabetes <span class="field field--name-title field--type-string field--label-hidden">Checking Cumulative High BP Exposure Hones CV Risk Prediction in Diabetes</span> <a href="/news/checking-cumulative-high-bp-exposure-hones-cv-risk-prediction-diabetes" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Checking%20Cumulative%20High%20BP%20Exposure%20Hones%20CV%20Risk%20Prediction%20in%20Diabetes.jpg?itok=ptfxaqRT" width="220" height="125" alt="Checking Cumulative High BP Exposure Hones CV Risk Prediction in Diabetes" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 09/14/2022 - 13:50</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Thinking of hypertension as damage that accumulates with time may sway practitioners to intervene earlier, Nelson Wang said.</div> Wed, 14 Sep 2022 17:50:10 +0000 hdellabella@crf.org 39475 at https://www.tctmd.com PARTNER 3: Two-Year Economic Outcomes https://www.tctmd.com/audio/partner-3-two-year-economic-outcomes <span class="field field--name-title field--type-string field--label-hidden">PARTNER 3: Two-Year Economic Outcomes</span> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Wed, 09/14/2022 - 12:40</span> <div class="field field--name-field-date field--type-datetime field--label-above"> <!-- <div class="field__label">Publish Date</div> --> <div class="field__item">1 week 4 days ago</div> </div> <div class="field field--name-field-teaser field--type-string-long field--label-above"> <!-- <div class="field__label">Teaser</div> --> <div class="field__item">C. Michael Gibson and David Cohen discuss cost implications of this TAVI versus SAVR randomized trial.</div> </div> Wed, 14 Sep 2022 16:40:15 +0000 hdellabella@crf.org 39473 at https://www.tctmd.com Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes https://www.tctmd.com/news/frailty-cardiac-surgery-common-linked-adverse-outcomes <span class="field field--name-title field--type-string field--label-hidden">Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes</span> <a href="/news/frailty-cardiac-surgery-common-linked-adverse-outcomes" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Frailty%20Before%20Cardiac%20Surgery%20Common%2C%20Linked%20to%20Adverse%20Outcomes.jpg?itok=nltKqf4k" width="220" height="125" alt="Frailty Before Cardiac Surgery Common, Linked to Adverse Outcomes" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 09/13/2022 - 16:20</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">(UPDATED) One frailty tool—the HFRS—was best at predicting patient-centered adverse events in short and midterm follow-up. </div> Tue, 13 Sep 2022 20:20:23 +0000 hdellabella@crf.org 39472 at https://www.tctmd.com Higher Step Counts Equal Better CV Health: UK Biobank https://www.tctmd.com/news/higher-step-counts-equal-better-cv-health-uk-biobank <span class="field field--name-title field--type-string field--label-hidden">Higher Step Counts Equal Better CV Health: UK Biobank</span> <a href="/news/higher-step-counts-equal-better-cv-health-uk-biobank" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Higher%20Step%20Counts%20Equal%20Better%20CV%20Health%20UK%20Biobank.jpg?itok=w1C2NR71" width="220" height="125" alt="Higher Step Counts Equal Better CV Health: UK Biobank" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 09/13/2022 - 15:21</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The analysis supports the idea that 10,000 steps may provide optimal protection, though there’s a benefit even with less.</div> Tue, 13 Sep 2022 19:21:30 +0000 hdellabella@crf.org 39471 at https://www.tctmd.com New-Onset AF Not Uncommon After Mitral TEER https://www.tctmd.com/news/new-onset-af-not-uncommon-after-mitral-teer <span class="field field--name-title field--type-string field--label-hidden">New-Onset AF Not Uncommon After Mitral TEER</span> <a href="/news/new-onset-af-not-uncommon-after-mitral-teer" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/New-Onset%20AF%20Not%20Uncommon%20After%20Mitral%20TEER.jpg?itok=V2oiACl1" width="220" height="125" alt="New-Onset AF Not Uncommon After Mitral TEER" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Tue, 09/13/2022 - 10:36</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">This is “a diagnosis that we should chase after and try to minimize as much as possible,” Fabio Lima says.</div> Tue, 13 Sep 2022 14:36:09 +0000 hdellabella@crf.org 39470 at https://www.tctmd.com COVID-19: TCTMD’s Dispatch for September 12 https://www.tctmd.com/news/COVID19-daily-dispatch <span class="field field--name-title field--type-string field--label-hidden">COVID-19: TCTMD’s Dispatch for September 12</span> <a href="/news/COVID19-daily-dispatch" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/woman%20smelling%20coffee%20grounds%20header.jpg?itok=nts7rvOT" width="220" height="130" alt="COVID-19: TCTMD’s Dispatch for September 12" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/56772" typeof="schema:Person" property="schema:name" datatype="">shuque@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 03/23/2020 - 16:54</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/todd-neale" hreflang="en">Todd Neale</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Eyeing the COVID endgame, the risks of avoiding vaccination, a hidden suicide crisis, lingering smell problems, and more.</div> Mon, 23 Mar 2020 20:54:22 +0000 shuque@crf.org 34352 at https://www.tctmd.com Artificial Sweeteners Linked to CVD, Stroke in French Adults: Observational Study https://www.tctmd.com/news/artificial-sweeteners-linked-cvd-stroke-french-adults-observational-study <span class="field field--name-title field--type-string field--label-hidden">Artificial Sweeteners Linked to CVD, Stroke in French Adults: Observational Study</span> <a href="/news/artificial-sweeteners-linked-cvd-stroke-french-adults-observational-study" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Artificial%20Sweeteners%20Linked%20to%20CVD%2C%20Stroke%20in%20French%20Adults%20Observational%20Study.jpg?itok=wEJ4X_Kj" width="220" height="125" alt="Artificial Sweeteners Linked to CVD, Stroke in French Adults: Observational Study" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Mon, 09/12/2022 - 13:51</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">However, given the potential risk of confounding, one expert believes strong conclusions can’t be drawn from the data. </div> Mon, 12 Sep 2022 17:51:05 +0000 hdellabella@crf.org 39469 at https://www.tctmd.com Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive https://www.tctmd.com/news/exercise-keeps-athletic-heart-supple-strong-healthy-jacc-deep-dive <span class="field field--name-title field--type-string field--label-hidden">Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive</span> <a href="/news/exercise-keeps-athletic-heart-supple-strong-healthy-jacc-deep-dive" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Exercise%20Keeps%20Athletic%20Heart%20Supple%2C%20Strong%2C%20Healthy%20JACC%20Deep%20Dive.jpg?itok=t2qpmO2s" width="220" height="125" alt="Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/09/2022 - 15:22</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/michael-oriordan" hreflang="en">Michael O&#039;Riordan</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Sports cardiology is a rapidly expanding field, and given exercise’s status as a wonder drug, it’s not just for elite athletes. </div> Fri, 09 Sep 2022 19:22:13 +0000 hdellabella@crf.org 39468 at https://www.tctmd.com Older Adults See Rebound in Rates of HF-Related Death: CDC Data https://www.tctmd.com/news/older-adults-see-rebound-rates-hf-related-death-cdc-data <span class="field field--name-title field--type-string field--label-hidden">Older Adults See Rebound in Rates of HF-Related Death: CDC Data</span> <a href="/news/older-adults-see-rebound-rates-hf-related-death-cdc-data" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Older%20Adults%20See%20Rebound%20in%20Rates%20of%20HF-Related%20Death%20CDC%20Data.jpg?itok=yj8ET8ym" width="220" height="125" alt="Older Adults See Rebound in Rates of HF-Related Death: CDC Data" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/09/2022 - 15:16</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/caitlin-e-cox" hreflang="en">Caitlin E. Cox</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Among US adults ages 75 and up, men and non-Hispanic white individuals had the highest risks between 1999 and 2019.</div> Fri, 09 Sep 2022 19:16:49 +0000 hdellabella@crf.org 39467 at https://www.tctmd.com FDA, Abbott Warn of Potential MitraClip Locking Malfunctions https://www.tctmd.com/news/fda-abbott-warn-potential-mitraclip-locking-malfunctions <span class="field field--name-title field--type-string field--label-hidden">FDA, Abbott Warn of Potential MitraClip Locking Malfunctions</span> <a href="/news/fda-abbott-warn-potential-mitraclip-locking-malfunctions" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/FDA%2C%20Abbott%20Warn%20of%20Potential%20MitraClip%20Locking%20Malfunctions.jpg?itok=wKqe9-6k" width="220" height="125" alt="FDA, Abbott Warn of Potential MitraClip Locking Malfunctions" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Fri, 09/09/2022 - 13:39</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">Incidents during procedures have been reported with all device models, both before and after clip deployment, at a rate of 1.3%.</div> Fri, 09 Sep 2022 17:39:01 +0000 hdellabella@crf.org 39466 at https://www.tctmd.com VITAL Rhythm Data May Flip the Script on AF Screening in Women https://www.tctmd.com/news/vital-rhythm-data-may-flip-script-af-screening-women <span class="field field--name-title field--type-string field--label-hidden">VITAL Rhythm Data May Flip the Script on AF Screening in Women</span> <a href="/news/vital-rhythm-data-may-flip-script-af-screening-women" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/VITAL%20Rhythm%20Data%20May%20Flip%20the%20Script%20on%20AF%20Screening%20in%20Women.jpg?itok=4XmmxhuA" width="220" height="125" alt="VITAL Rhythm Data May Flip the Script on AF Screening in Women" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/08/2022 - 14:15</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/la-mckeown" hreflang="en">L.A. McKeown</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">When height and body size were substituted for BMI, women had a higher risk of AF than men across the board.</div> Thu, 08 Sep 2022 18:15:28 +0000 hdellabella@crf.org 39465 at https://www.tctmd.com Beyond the Shining Lights and Science at ESC: Bullying Works in Shadows https://www.tctmd.com/news/beyond-shining-lights-and-science-esc-bullying-works-shadows <span class="field field--name-title field--type-string field--label-hidden">Beyond the Shining Lights and Science at ESC: Bullying Works in Shadows</span> <a href="/news/beyond-shining-lights-and-science-esc-bullying-works-shadows" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2021-04/TCTMD21-Over-the-Wire-650x330-02%20%281%29.jpg?itok=y0qHBJPh" width="220" height="125" alt="Beyond the Shining Lights and Science at ESC: Bullying Works in Shadows" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/08/2022 - 10:40</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/mamas-mamas-bmbch" hreflang="en">Mamas Mamas, BMBCh</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">If cardiology societies truly hope to achieve diversity and representation, then they must take a more proactive role.</div> Thu, 08 Sep 2022 14:40:05 +0000 hdellabella@crf.org 39464 at https://www.tctmd.com Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI https://www.tctmd.com/news/late-bleeding-not-rare-ups-mortality-after-tavi-all-asian-cohort-ocean-tavi <span class="field field--name-title field--type-string field--label-hidden">Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI</span> <a href="/news/late-bleeding-not-rare-ups-mortality-after-tavi-all-asian-cohort-ocean-tavi" hreflang="en"><img src="https://d18mqtxkrsjgmh.cloudfront.net/public/styles/medium/public/2022-09/Late%20Bleeding%20Not%20Rare%2C%20Ups%20Mortality%20After%20TAVI%20in%20All-Asian%20Cohort%20OCEAN-TAVI.jpg?itok=3sYpc4Bp" width="220" height="125" alt="Late Bleeding Not Rare, Ups Mortality After TAVI in All-Asian Cohort: OCEAN-TAVI" loading="lazy" typeof="foaf:Image" class="image-style-medium" /> </a> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span lang="" about="/user/84234" typeof="schema:Person" property="schema:name" datatype="">hdellabella@crf.org</span></span> <span class="field field--name-created field--type-created field--label-hidden">Thu, 09/08/2022 - 10:32</span> <div class="field field--name-field-author field--type-entity-reference field--label-hidden"> <a href="/staff/yael-l-maxwell" hreflang="en">Yael L. Maxwell</a> </div> <div class="field field--name-field-teaser field--type-string-long field--label-hidden field__item">The findings have implications for postdischarge antithrombotic regimens, with experts stressing the less is more approach.</div> Thu, 08 Sep 2022 14:32:33 +0000 hdellabella@crf.org 39463 at https://www.tctmd.com